Related Experiment Videos
What is new in paediatric medication safety?
Stacie Kahn1, Erika L Abramson1,2
1Department of Pediatrics, NewYork-Presbyterian Hospital/Weill Cornell Medicine, New York, USA.
Archives of Disease in Childhood
|August 30, 2018
Summary
New advancements in paediatric medication safety aim to reduce common medical errors in children. Technologies like CPOE, barcoding, and SMART pumps are improving medication safety from ordering to administration.
Area of Science:
- Pediatric Medicine
- Patient Safety
- Health Informatics
Background:
- Medication errors are frequent medical errors, with children being a vulnerable population.
- Errors can occur at any stage of the medication process, impacting patient safety.
- Improving medication safety in pediatrics is critical for child health outcomes.
Purpose of the Study:
- To review recent advancements in pediatric medication safety.
- To highlight innovations across the entire medication process: ordering, transcribing, dispensing, and administration.
- To identify remaining gaps in pediatric medication safety.
Main Methods:
- Review of current literature and emerging technologies in pediatric medication safety.
- Focus on interventions like Computerized Provider Order Entry (CPOE) with clinical decision support.
- Examination of barcoding, SMART pumps, mobile applications, and workflow management systems.
Main Results:
- Computerized provider order entry with clinical decision support enhances medication safety.
- Barcoding technologies and SMART pumps improve medication administration accuracy.
- Mobile applications and workflow systems show promise in pilot studies.
Conclusions:
- Technological interventions are crucial for advancing pediatric medication safety.
- Continued focus and research are needed to address remaining safety gaps.
- Implementing these advancements can create a safer environment for pediatric patients.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
197
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
197
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
180
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
180
Drug Dosing: Infants and Children
183
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
183
Pharmacokinetics in Pediatric Patients: Drug Metabolism
142
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
142
Pharmacokinetics in Pediatric Patients: Drug Excretion
153
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
153
Factors Affecting Drug Response: Overview
2.7K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K